This week we explore promising developments in CRISPR genome editing, also known as clustered regularly interspaced short palindromic repeats, a bacterial defense system. We also look at two of the latest U.S. Food and Drug Administration’s approvals, including another one for a surgical robot that leverages artificial intelligence and a nerve stimulation ... READ MORE >
life sciences
5 things to know in life sciences: Week of September 6
As the threat of the delta variant continues to mount, the Biden administration has released plans to extend its vaccine mandate to U.S. companies. Affecting over 80 million U.S. workers, we expect there to be significant conversation on this topic in the coming months. This week, we also dig into Pfizer’s impressive team of “variant hunters” who work around ... READ MORE >
5 things to know in life sciences: Week of August 23
We often hear about rare and orphan diseases and think they must be, well, rare. For every individual rare disease, that is true. But when considered together, a surprising number of people are affected by one of the thousands of known rare diseases. This week we share two stories of how big data and machine learning are being used to better identify and ... READ MORE >
5 things to know in life sciences: Week of August 16
With the school year starting and office reopening plans shifting, many people are unsure of what activities they should be comfortable doing and what they should avoid in the face of the delta variant. Instead of asking experts what other people should do, this week we look at what decisions those experts are making for themselves. We also look at the ... READ MORE >
5 things to know in life sciences: Week of August 9
With eyes on infrastructure policymaking this week, our roundup takes a look at the components of the Democrats' $3.5 trillion budget framework that could affect the life sciences industry. We also highlight a major investment in surgical robotics, the performance of companies post-merger with a special purpose acquisition company and share which of the ... READ MORE >
5 things to know in life sciences: Week of August 2
This week we start with a look at the potential for gene and cell therapy to radically change health care over the coming decade. Although there are few approved drugs using these technologies today, the pipeline of candidates in all phases of clinical studies is full of potential cell and gene therapy treatments. We also highlight recent life sciences ... READ MORE >
5 things to know in life sciences: Week of July 26
This week we highlight the United States Food and Drug Administration’s approval of an insulin biosimilar and their granting of its status as interchangeable with the name brand drug. This promises significant savings for diabetic patients who often face financial hardships because of the cost of care. We also look at an artificial intelligence tool for ... READ MORE >
5 things to know in life sciences: Week of July 19
This week, we explore an innovative artificial intelligence app used to treat mental health issues. We consider opportunities related to investments in women’s health. We also look at a few pharma giants, including two with a commitment to supply COVID-19 vaccines to Africa and one with a series of big wins and losses in its second-quarter earnings ... READ MORE >
5 things to know in life sciences: Week of July 12
The medical devices sector is booming with activity as evidenced by the 114% year-over-year increase in industry-funded medical devices trial starts for the period of January through May. This week, we explore new technologies contributing to the medical devices boom, including a miniature surgical robot for needle-based procedures and new magnetic resonance ... READ MORE >
5 things to know in life sciences: Week of June 28
Diabetes effects more than 10% of the U.S. population and brings with it the risk of serious complications, high health care costs and daily difficulties for patients that are afflicted with it. This week we look at the potential of using an old drug to help people with type 1 diabetes as well as the promise of a common tool used for type 1 patients to now ... READ MORE >